Determining buffer conditions for downstream processing of VLP-based recombinant hepatitis B surface antigen using multimodal resins in bind-elute and flow-through purification modes

被引:10
作者
Goodarzi, Maryam Moazami [1 ]
Jalalirad, Reza [1 ]
Doroud, Delaram [1 ]
Hozouri, Hamidreza [2 ]
Aghasadeghi, Mohammadreza [3 ,4 ]
Paryan, Mahdi [1 ]
机构
[1] Pasteur Inst Iran, Dept Res & Dev Prod & Res Complex, Karaj 3159915111, Iran
[2] Pasteur Inst Iran, Dept Qual Management, Prod & Res Complex, Karaj 3159915111, Iran
[3] Pasteur Inst Iran, Dept Hepatitis & AIDS, Tehran 1316943551, Iran
[4] Pasteur Inst Iran, Viral Vaccine Res Ctr, Tehran 1316943551, Iran
关键词
VIRUS-LIKE PARTICLES; ANTIBODY-CAPTURE; PROTEIN-BINDING; CHROMATOGRAPHY; HBSAG; IDENTIFICATION; EXTRACTION; PASTORIS; EXCHANGE; VACCINES;
D O I
10.1038/s41598-023-37614-y
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The difficulties in purification of VLP-based recombinant hepatitis B surface antigen (rHBsAg) are mainly emerged from inefficient semi-purification step plus proteins physicochemical properties and these issues make the downstream processing (DSP) very lengthy and expensive. In this study, optimization of rHBsAg (recombinantly-expressed in Pichia pastoris) DSP was performed using selection of buffering conditions in the semi-purification step. In the semi-purification optimization step, up to 73% of the protein impurities were eliminated and the utmost increase in rHBsAg purity (ca. 3.6-fold) was achieved using 20 mM sodium acetate, pH 4.5. By using rHBsAg binding and nonbinding situations obtained from the response surface plot in design of experiments (DOE), additional bind-elute and flow-through purification mode experiments were conducted and rHBsAg with high purity (near 100%) and recovery (>83%) was achieved. Following assessment of critical quality attributes (i.e., purity, particle size distribution, host cell DNA, host cell protein, secondary structures, specific activity and relative potency), it was indicated that the characteristics of rHBsAg purified by the new DSP were similar or superior to the ones obtained from conventional DSP. The purification performance of the resin was constantly retained (97-100%) and no significant resin damage took place after 10 adsorption-elution-cleaning cycles. The new DSP developed for production of rHBsAg in this study can substitute the conventional one with granting satisfactory target protein quality, long-lasting resin efficacy, shorter and less expensive process. This process may be also employable for purification of both non-VLP- and VLP- based target proteins expressed in the yeast.
引用
收藏
页数:21
相关论文
共 54 条
[1]   Chromatography-free recovery of biopharmaceuticals through aqueous two-phase processing [J].
Azevedo, Ana M. ;
Rosa, Paula A. J. ;
Ferreira, I. Filipa ;
Aires-Barros, M. Raquel .
TRENDS IN BIOTECHNOLOGY, 2009, 27 (04) :240-247
[2]   A novel multimodal chromatography based single step purification process for efficient manufacturing of an E. coli based biotherapeutic protein product [J].
Bhambure, Rahul ;
Gupta, Darpan ;
Rathore, Anurag S. .
JOURNAL OF CHROMATOGRAPHY A, 2013, 1314 :188-198
[3]   The future of host cell protein (HCP) identification during process development and manufacturing linked to a risk-based management for their control [J].
Bracewell, Daniel G. ;
Francis, Richard ;
Smales, C. Mark .
BIOTECHNOLOGY AND BIOENGINEERING, 2015, 112 (09) :1727-1737
[4]   A monolith purification process for virus-like particles from yeast homogenate [J].
Burden, Claire S. ;
Jin, Jing ;
Podgornik, Ales ;
Bracewell, Daniel G. .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2012, 880 :82-89
[5]   PRODUCTION AND IMMUNOLOGICAL ANALYSIS OF RECOMBINANT HEPATITIS-B VACCINE [J].
EMINI, EA ;
ELLIS, RW ;
MILLER, WJ ;
MCALEER, WJ ;
SCOLNICK, EM ;
GERETY, RJ .
JOURNAL OF INFECTION, 1986, 13 :3-&
[6]   Integrated purification of a nanobody using ammonium sulfate precipitation and Capto MMC [J].
Fan, Xiying ;
Liang, Yunlong ;
Li, Fei ;
Yu, Jianli ;
Song, Haipeng ;
Feng, Dongxiao ;
Xian, Mo ;
Liu, Wenshuai ;
Nian, Rui .
JOURNAL OF CHEMICAL TECHNOLOGY AND BIOTECHNOLOGY, 2020, 95 (01) :246-254
[7]   Comparison of different ligand densities for the manufacture of CB.Hep-1 immunosorbents [J].
Gómez, L ;
Hernández, R ;
Ibarra, N ;
Valdés, R ;
Campos, Y ;
Tamayo, A ;
Fernández, D ;
Figueroa, A ;
Alvarez, T ;
Montero, JA .
JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS, 2002, 52 (03) :151-159
[8]   HIV-1 derived peptides fused to HBsAg affect its immunogenicity [J].
Gonzalez, Minerva Cervantes ;
Kostrzak, Anna ;
Guetard, Denise ;
Pniewski, Tomasz ;
Sala, Monica .
VIRUS RESEARCH, 2009, 146 (1-2) :107-114
[9]   Characterization of the structural modifications accompanying the loss of HBsAg particle immunogenicity [J].
Greiner, Vanille J. ;
Manin, Catherine ;
Larquet, Eric ;
Ikhelef, Nabila ;
Greco, Frederic ;
Naville, Sophie ;
Milhiet, Pierre-Emmanuel ;
Ronzon, Frederic ;
Klymchenko, Andrey ;
Mely, Yves .
VACCINE, 2014, 32 (09) :1049-1054
[10]   A tool for increasing the lifetime of chromatography resins [J].
Gronberg, Anna ;
Eriksson, Malin ;
Ersoy, Maria ;
Johansson, Hans J. .
MABS, 2011, 3 (02) :192-202